CUAMC
MIRM icon

China Universal Asset Management Company’s Mirum Pharmaceuticals MIRM Stock Holding History

China Universal Asset Management Company’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
9,705
-1,003
-9% -$101K 0.07% 192
2026
Q1 		$989K Buy
10,708
+2,333
+28% +$219K 0.07% 192
2025
Q4 		$662K Sell
8,375
-431
-5% -$30.9K 0.05% 230
2025
Q3 		$646K Sell
8,806
-1,143
-11% -$72.7K 0.05% 218
2025
Q2 		$506K Buy
9,949
+118
+1% +$5.25K 0.05% 240
2025
Q1 		$443K Sell
9,831
-348
-3% -$16.4K 0.04% 254
2024
Q4 		$421K Buy
10,179
+1,003
+11% +$41.8K 0.04% 266
2024
Q3 		$358K Buy
9,176
+3,639
+66% +$145K 0.04% 251
2024
Q2 		$189K Sell
5,537
-3,415
-38% -$89.5K 0.03% 250
2024
Q1 		$225K Buy
8,952
+3,558
+66% +$97.8K 0.03% 275
2023
Q4 		$159K Buy
5,394
+4,408
+447% +$133K 0.03% 226
2023
Q3 		$31.2K Buy
986
+488
+98% +$13.4K 0.01% 265
2023
Q2 		$12.9K Sell
498
-1
-0.2% -$27 ﹤0.01% 303
2023
Q1 		$12K Buy
499
+125
+33% +$2.85K ﹤0.01% 269
2022
Q4 		$7.29K Buy
374
+29
+8% +$573 ﹤0.01% 256
2022
Q3 		$7K Buy
+345
New +$8.31K ﹤0.01% 234

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's MIRM Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Mirum Pharmaceuticals (MIRM) stake by 9.4% in Q2 2026, selling an estimated $101K and leaving 9,705 shares worth $1.14M. The position accounts for 0.07% of the portfolio, ranked #192.

China Universal Asset Management Company first reported a position in MIRM in Q3 2022 and has held it in 16 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • China Universal Asset Management Company held 9,705 shares of Mirum Pharmaceuticals worth $1.14M as of Q2 2026.
  • China Universal Asset Management Company sold 1,003 Mirum Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • Mirum Pharmaceuticals made up 0.07% of China Universal Asset Management Company's portfolio in Q2 2026, its #192 holding.
  • China Universal Asset Management Company first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.